<DOC>
	<DOCNO>NCT00546663</DOCNO>
	<brief_summary>This open-label pilot study safety tolerability 7 % hypertonic saline inhale twice daily 14 day infant CF , 12 30 month age .</brief_summary>
	<brief_title>Tolerability Inhaled Hypertonic Saline Infants With Cystic Fibrosis</brief_title>
	<detailed_description>The efficacy safety hypertonic saline ( HS ) CF patient 6 year age demonstrate clinical trial 2 48 week ' duration . Based result , large randomize , placebo-controlled trial efficacy safety 7 % HS administer twice daily 48 week infant CF , 4 15 month age enrollment , plan ( Infant Study Inhaled Saline ( ISIS ) trial ) . It anticipate 150 infant 16 site enrol ISIS trial . To date , evaluation safety HS infant CF small single-dose study . There evaluation tolerability chronic HS administration . The goal study assess safety tolerability exposure 14 day 7 % HS administer twice daily infant CF , prior enrol subject plan large , randomize , control trial . Conduct study provide evidence tolerability chronic HS administration infant CF estimate proportion infant tolerate chronic HS treatment . The result use establish appropriate measure tolerability enrollment ISIS trial , refine sample size estimate account withdrawal due intolerance HS .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Diagnosis CF define one clinical feature CF document sweat chloride â‰¥ 60 mEq/L quantitative pilocarpine iontophoresis test genotype show two well characterized disease cause mutation Informed consent parent legal guardian 1230 month age enrollment Wheezing baseline evaluation enrollment visit Oxygen saturation &lt; 95 % baseline evaluation enrollment visit Acute intercurrent respiratory infection , define increase cough , wheeze , respiratory rate , new rhinorrhea , nasal congestion rhinorrhea , onset week precede enrollment visit Investigational drug use within 30 day prior enrollment visit Known intolerance albuterol Current enrollment therapeutic clinical trial Condition situation , opinion investigator , would affect ability patient family complete study procedure</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>30 Months</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Cystic Fibrosis , hypertonic saline</keyword>
</DOC>